BCR
Breakpoint cluster region protein
Also known as: ALL, BCR_HUMAN, BCR1, CML, D22S11, D22S662, PHL
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P11274
- Gene
- BCR
- Ensembl
- ENSG00000186716
- Chromosome
- 22
- Canonical length
- 1271 aa
- Protein class
- Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Plasma membrane,Cytosol
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
A reciprocal translocation between chromosomes 22 and 9 produces the Philadelphia chromosome, which is often found in patients with chronic myelogenous leukemia. The chromosome 22 breakpoint for this translocation is located within the BCR gene. The translocation produces a fusion protein which is encoded by sequence from both BCR and ABL, the gene at the chromosome 9 breakpoint. Although the BCR-ABL fusion protein has been extensively studied, the function of the normal BCR gene product is not clear. The unregulated tyrosine kinase activity of BCR-ABL1 contributes to the immortality of leukaemic cells. The BCR protein has serine/threonine kinase activity and is a GTPase-activating protein for p21rac and other kinases. Two transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jan 2020]
Canonical amino-acid sequenceUniProt
1271 residues, UniProt reviewed canonical sequence.
>P11274|BCR
1 MVDPVGFAEA WKAQFPDSEP PRMELRSVGD IEQELERCKA SIRRLEQEVN QERFRMIYLQ
61 TLLAKEKKSY DRQRWGFRRA AQAPDGASEP RASASRPQPA PADGADPPPA EEPEARPDGE
121 GSPGKARPGT ARRPGAAASG ERDDRGPPAS VAALRSNFER IRKGHGQPGA DAEKPFYVNV
181 EFHHERGLVK VNDKEVSDRI SSLGSQAMQM ERKKSQHGAG SSVGDASRPP YRGRSSESSC
241 GVDGDYEDAE LNPRFLKDNL IDANGGSRPP WPPLEYQPYQ SIYVGGMMEG EGKGPLLRSQ
301 STSEQEKRLT WPRRSYSPRS FEDCGGGYTP DCSSNENLTS SEEDFSSGQS SRVSPSPTTY
361 RMFRDKSRSP SQNSQQSFDS SSPPTPQCHK RHRHCPVVVS EATIVGVRKT GQIWPNDGEG
421 AFHGDADGSF GTPPGYGCAA DRAEEQRRHQ DGLPYIDDSP SSSPHLSSKG RGSRDALVSG
481 ALESTKASEL DLEKGLEMRK WVLSGILASE ETYLSHLEAL LLPMKPLKAA ATTSQPVLTS
541 QQIETIFFKV PELYEIHKEF YDGLFPRVQQ WSHQQRVGDL FQKLASQLGV YRAFVDNYGV
601 AMEMAEKCCQ ANAQFAEISE NLRARSNKDA KDPTTKNSLE TLLYKPVDRV TRSTLVLHDL
661 LKHTPASHPD HPLLQDALRI SQNFLSSINE EITPRRQSMT VKKGEHRQLL KDSFMVELVE
721 GARKLRHVFL FTDLLLCTKL KKQSGGKTQQ YDCKWYIPLT DLSFQMVDEL EAVPNIPLVP
781 DEELDALKIK ISQIKNDIQR EKRANKGSKA TERLKKKLSE QESLLLLMSP SMAFRVHSRN
841 GKSYTFLISS DYERAEWREN IREQQKKCFR SFSLTSVELQ MLTNSCVKLQ TVHSIPLTIN
901 KEDDESPGLY GFLNVIVHSA TGFKQSSNLY CTLEVDSFGY FVNKAKTRVY RDTAEPNWNE
961 EFEIELEGSQ TLRILCYEKC YNKTKIPKED GESTDRLMGK GQVQLDPQAL QDRDWQRTVI
1021 AMNGIEVKLS VKFNSREFSL KRMPSRKQTG VFGVKIAVVT KRERSKVPYI VRQCVEEIER
1081 RGMEEVGIYR VSGVATDIQA LKAAFDVNNK DVSVMMSEMD VNAIAGTLKL YFRELPEPLF
1141 TDEFYPNFAE GIALSDPVAK ESCMLNLLLS LPEANLLTFL FLLDHLKRVA EKEAVNKMSL
1201 HNLATVFGPT LLRPSEKESK LPANPSQPIT MTDSWSLEVM SQVQVLLYFL QLEAIPAPDS
1261 KRQSILFSTE VLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BCR can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 61 nTPM
Expression across tissuesHPA
Tissue
- basal ganglia: 61 nTPM
- cerebral cortex: 36 nTPM
- amygdala: 35 nTPM
- hippocampal formation: 34 nTPM
- bone marrow: 33 nTPM
- midbrain: 26 nTPM
Single-cell type
- hematopoietic stem cells: 262 nCPM
- esophageal apical cells: 179 nCPM
- bergmann glia: 156 nCPM
- vascular endothelial cells: 155 nCPM
- corticotrophs: 147 nCPM
- thymocytes: 147 nCPM
Immune cell
- gdT-cell: 3.1 nTPM
- naive CD8 T-cell: 1.7 nTPM
- memory CD4 T-cell: 1.6 nTPM
- memory CD8 T-cell: 1.5 nTPM
- NK-cell: 1.5 nTPM
- total PBMC: 1.4 nTPM
Brain region
- basal ganglia: 171 nTPM
- hippocampal formation: 128 nTPM
- thalamus: 108 nTPM
- amygdala: 105 nTPM
- cerebral cortex: 98 nTPM
- midbrain: 92 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about BCR.
Disease | AllUniProt
Conditions BCR is implicated in, by any mechanism.
- Leukemia, chronic myeloid (CML) MIM:608232
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.3
- gnomAD pLI
- 0.99
- gnomAD missense Z
- 0.89
- DepMap mean gene effect
- 0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin cytoskeleton organization
- activation of GTPase activity
- brain development
- cellular response to lipopolysaccharide
- definitive hemopoiesis
- focal adhesion assembly
- homeostasis of number of cells
- inner ear morphogenesis
- intracellular protein transmembrane transport
- keratinocyte differentiation
- macrophage migration
- modulation of chemical synaptic transmission
- negative regulation of blood vessel remodeling
- negative regulation of inflammatory response
- negative regulation of macrophage migration
- negative regulation of neutrophil degranulation
- negative regulation of reactive oxygen species metabolic process
- neuromuscular process controlling balance
- neutrophil degranulation
- phagocytosis
- positive regulation of phagocytosis
- protein phosphorylation
- regulation of cell cycle
- regulation of Rho protein signal transduction
- regulation of small GTPase mediated signal transduction
- regulation of vascular permeability
- renal system process
- signal transduction
- small GTPase-mediated signal transduction
- negative regulation of cellular extravasation
- negative regulation of respiratory burst
Molecular functions
- ATP binding
- GTPase activator activity
- guanyl-nucleotide exchange factor activity
- protein serine kinase activity
- protein serine/threonine kinase activity
- protein tyrosine kinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- C2 domain
- Rho GTPase-activating protein domain
- Dbl homology domain
- Guanine-nucleotide dissociation stimulator, CDC24, conserved site
- Pleckstrin homology domain
- Rho GTPase activation protein
- PH-like domain superfamily
- C2 domain superfamily
- Dbl homology (DH) domain superfamily
- Abr/Bcr
- C2 domain
- RhoGAP domain
- RhoGEF domain
- PH domain
- Bcr-Abl oncoprotein oligomerisation
- Bcr-Abl oncoprotein oligomerisation domain superfamily
- Bcr-Abl oncoprotein oligomerisation domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of BCR in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BCR as an antibody target. Whether an autoantibody or antibody against BCR could matter depends on whether native BCR is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BCR is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label BCR as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...